- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Fischer introduces next-generation digital mammography system
The SenoScan2 slot scanning digital mammography (SSDM) system from Fischer Imaging is being introduced at the RSNA meeting. Fischer designs, manufactures, and markets medical imaging systems for screening and diagnosis.
The SenoScan2 slot scanning digital mammography (SSDM) system from Fischer Imaging is being introduced at the RSNA meeting. Fischer designs, manufactures, and markets medical imaging systems for screening and diagnosis.
The system mixes high image resolution and reduced radiation dose, while virtually eliminating motion artifacts, according to the company. Fischer calls it the next generation of slot scanning technology and claims SenoScan2 is the only digital mammography unit to offer both 50- and 25-micron native diagnostic resolution.
SenoScan2 will be included in a three-year global agreement signed last month with Philips Medical Systems. Under terms of the agreement, Philips will sell, service, and support a specialized version of Fischer's digital mammography system integrated with Philips' image processing and user interface.
"The SenoScan2 enables users to fully maximize image quality with customizable workflow and image management capabilities in a series of robust workstations that will scale to their needs," said Harris Ravine, president and CEO of Fischer. "The partnership with Philips will dramatically expand access to powerful end-to-end digital mammography solutions."
Fischer's slot scanning technology uses a tightly collimated x-ray beam that scans in precise alignment with a narrow slotted image receptor. The design essentially eliminates the negative effects of scatter radiation without requiring the use of a grid. The result is sharp, high-resolution images with up to a 60% reduction in radiation dose, according to the company.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
Mammography-Based AI Abnormality Scoring May Improve Prediction of Invasive Upgrade of DCIS
April 9th 2024Emerging research suggests that an artificial intelligence (AI) score of 75 or greater for mammography abnormalities more than doubles the likelihood of invasive upgrade of ductal carcinoma in situ (DCIS) diagnosed with percutaneous biopsy.
Mammography Study: AI Improves Breast Cancer Detection and Reduces Reading Time with DBT
April 3rd 2024An emerging artificial intelligence (AI) model demonstrated more than 12 percent higher specificity and reduced image reading time by nearly six seconds in comparison to unassisted radiologist interpretation of digital breast tomosynthesis (DBT) images.
